| Company
| Aggregate Score
| P/E ratio
| Gross margin
| EBIT margin
| ROA
| Net income per employee
|
| Scope Fluidics S.A.
|
| 6.9
| -1,599.3%
| -4,886.7%
| 39.0%
| €197.69K
|
| Intelligent Bio Solutions Inc.
|
| -0.04
| 43.1%
| -331.7%
| -108.2%
| -€188.56K
|
| Stella Diagnostics Inc.
|
| -3.2
| -62.2%
| -656.6%
| -417.6%
| -€645.21K
|
| Vimian Group AB (publ)
|
| 6.1
| 68.6%
| 14.3%
| 2.8%
| €26.08K
|
| FALCO HOLDINGS Co., Ltd.
|
| 12
| 31.2%
| 5.5%
| 5.4%
| €9.63K
|
| AroCell AB (publ)
|
| -3.1
| 20.6%
| -75.1%
| -36.0%
| -€183.59K
|
| Hudson Global, Inc.
|
| -1.3
| 48.8%
| -2.5%
| -4.1%
| -€4.30K
|
| Wellfully Limited
|
| -0.75
| 36.7%
| -138.7%
| -57.1%
| €0.00
|
| Genetic Technologies Limited
|
| -0.48
| 9.3%
| -98.6%
| -194.2%
| -€130.28K
|
| Thyrocare Technologies Limited
|
| 49
| 61.7%
| 29.1%
| 0.0%
| €5.86K
|
| Bioqual, Inc.
|
| -37
| -3.9%
| -3.9%
| -1.8%
| -€3.27K
|
| Fulgent Genetics, Inc.
|
| -15
| 41.2%
| -22.5%
| -3.5%
| -€28.40K
|
| Cryosite Limited
|
| 20
| 61.4%
| 17.3%
| 9.6%
| €43.69K
|
| Fleury S.A.
|
| 11
| 26.9%
| 15.0%
| 4.4%
| €3.66K
|
| Lumibird SA
|
| 27
| 9.6%
| 10.6%
| 2.5%
| €10.44K
|
| NanoRepro AG
|
| -10
| 41.6%
| -80.4%
| -5.2%
| -€92.99K
|
| PharmChem, Inc.
|
| 15
| 63.7%
| 27.3%
| 50.5%
| €133.11K
|
| Exagen Inc.
|
| -8.3
| 59.9%
| -19.6%
| -30.3%
| -€79.04K
|
| Guangzhou Kingmed Diagnostics Group Co., Ltd.
|
| -25
| 32.5%
| -7.4%
| -5.7%
| -€6.70K
|
| Biodesix, Inc.
|
| -1.2
| 57.8%
| -40.6%
| -44.6%
| -€125.66K
|
| PT Prodia Widyahusada Tbk
|
| 12
| 56.0%
| 10.4%
| 8.7%
| €3.86K
|
| Verici Dx plc
|
| -0.0093
| 100.0%
| -182.9%
| -78.4%
| -€268.25K
|
| PT Diagnos Laboratorium Utama Tbk
|
| -77
| 41.4%
| -0.7%
| -0.8%
| -€1.35K
|
| Proteome Sciences plc
|
| -0.027
| -0.7%
| -50.1%
| -39.9%
| -€106.11K
|
| NovelStem International Corp.
|
| 2.1
| 100.0%
| -8,034.7%
| 4,564.1%
| €0.00
|
| Illumina, Inc.
|
| 20
| 66.2%
| 18.3%
| 11.4%
| €68.00K
|
| Sapporo Clinical Laboratory Inc.
|
| 7.9
| 30.5%
| 6.6%
| 2.8%
| €2.90K
|
| DarioHealth Corp.
|
| -6.3
| 56.9%
| -163.7%
| -4.3%
| -€22.40K
|
| iMD Companies, Inc.
|
| -1.7
| 19.3%
| -139.8%
| -121.0%
| €0.00
|
| Optigenex Inc.
|
| -0.0000043
| -2.6%
| 178.3%
| -233.1%
| €0.00
|
| Beijing Strong Biotechnologies, Inc.
|
| 19
| 80.1%
| 34.8%
| 8.2%
| €49.64K
|
| Genomic Vision SA
|
| -0.065
| 41.8%
| -870.4%
| -268.4%
| -€321.88K
|
| IDEXX Laboratories, Inc.
|
| 41
| 61.7%
| 31.3%
| 30.3%
| €81.04K
|
| Yourgene Health Plc
|
| -0.014
| 62.4%
| -78.5%
| -23.6%
| -€52.44K
|
| Syneos Health, Inc.
|
| 62
| 22.1%
| 5.4%
| 0.9%
| €2.15K
|
| Selvita S.A.
|
| 1.1K
| 79.4%
| 2.6%
| 0.1%
| €111.98
|
| Burning Rock Biotech Limited
|
| -1.2
| 73.0%
| -23.1%
| -14.9%
| -€22.63K
|
| Medicalsystem Biotechnology Co., Ltd.
|
| 43
| 39.6%
| 4.4%
| 2.6%
| €5.63K
|
| Enzo Biochem, Inc.
|
| -1.5
| 43.8%
| -39.0%
| -33.2%
| -€146.34K
|
| Microba Life Sciences Limited
|
| -4
| 47.5%
| -120.2%
| -31.5%
| €0.00
|
| Myriad Genetics, Inc.
|
| -1.2
| 70.4%
| -50.1%
| -58.3%
| -€127.00K
|
| Dirui Industrial Co.,Ltd.
|
| -27
| 35.3%
| -34.9%
| -5.0%
| -€9.53K
|
| Shanghai Labway Clinical Laboratory Co., Ltd.
|
| -55
| 24.5%
| 0.9%
| -2.9%
| -€6.41K
|
| Sotera Health Company
|
| 62
| 56.0%
| 30.7%
| 1.7%
| €16.03K
|
| Exact Sciences Corporation
|
| -11
| 67.4%
| -32.3%
| -16.7%
| -€124.06K
|
| Vijaya Diagnostic Centre Limited
|
| 66
| 87.7%
| 39.7%
| 0.0%
| €6.81K
|
| Rhythm Biosciences Limited
|
| -4.6
| 11.7%
| -119.2%
| -135.2%
| €0.00
|
| Aspira Women's Health Inc.
|
| -0.27
| 63.9%
| -107.7%
| -148.0%
| -€141.97K
|
| Chemclin Diagnostics Co., Ltd.
|
| 51
| 68.0%
| 13.8%
| 3.2%
| €9.72K
|
| Rennova Health, Inc.
|
| -0.0055
| 59.5%
| 7.3%
| -38.2%
| -€69.86K
|
| Spectral Medical Inc.
|
| -12
| 59.8%
| -461.5%
| -389.0%
| -€459.89K
|
| Healius Limited
|
| -4.1
| 29.7%
| 0.0%
| -8.5%
| -€20.83K
|
| Lumos Diagnostics Holdings Limited
|
| -1.5
| 61.9%
| -44.7%
| -34.5%
| €0.00
|
| OpGen, Inc.
|
| 3.7
| 100.8%
| 41.2%
| 119.9%
| €115.32K
|
| Puriblood Medical Co., Ltd.
|
| -147
| 53.2%
| 0.1%
| -2.9%
| -€4.61K
|
| Abingdon Health Plc
|
| -0.053
| 46.6%
| -36.4%
| -26.3%
| -€26.24K
|
| Medpace Holdings, Inc.
|
| 20
| 31.1%
| 21.5%
| 24.7%
| €63.68K
|
| Standard BioTools Inc.
|
| -3.1
| 47.9%
| -96.6%
| -23.8%
| -€180.94K
|
| DIVA Laboratories, Ltd.
|
| 26
| 31.0%
| 13.0%
| 6.3%
| €0.00
|
| Waters Corporation
|
| 31
| 62.4%
| 26.5%
| 13.3%
| €74.07K
|
| Trinity Biotech plc
|
| -0.35
| 32.1%
| -42.0%
| -37.4%
| -€85.11K
|
| Sera Prognostics, Inc.
|
| -1.7
| -281.1%
| -38,918.9%
| -30.2%
| -€449.35K
|
| Devyser Diagnostics AB (publ)
|
| -49
| 81.6%
| -16.2%
| -9.9%
| -€34.71K
|
| Meridian Bioscience, Inc.
|
| -546
| 56.6%
| 2.1%
| -0.6%
| -€3.40K
|
| Epigenomics AG
|
| -0.072
| 75.8%
| -1,263.3%
| -38.5%
| -€221.36K
|
| NeoGenomics, Inc.
|
| -1.8
| 43.5%
| -17.0%
| -8.3%
| -€44.75K
|
| Interpace Biosciences, Inc.
|
| 0.75
| 64.6%
| 13.3%
| 40.0%
| €37.60K
|
| Mettler-Toledo International Inc.
|
| 29
| 59.7%
| 29.1%
| 23.7%
| €45.32K
|
| 23andMe Holding Co.
|
| -0.056
| 53.3%
| -129.4%
| -163.0%
| -€364.60K
|
| Natera, Inc.
|
| -73
| 63.7%
| -16.6%
| -17.0%
| -€60.64K
|
| Star Equity Holdings, Inc.
|
| -1
| 32.9%
| -1.8%
| -5.4%
| -€28.29K
|
| Inotiv, Inc.
|
| -1.3
| 18.1%
| -1.3%
| -8.9%
| -€30.12K
|
| WuXi AppTec Co., Ltd.
|
| 14
| 43.8%
| 38.4%
| 16.4%
| €43.95K
|
| Joinn Laboratories(China)Co.,Ltd.
|
| 65
| 25.3%
| -5.1%
| 2.4%
| €11.28K
|
| SenzaGen AB
|
| -9.7
| 65.1%
| -29.1%
| -16.4%
| -€43.46K
|
| Precipio, Inc.
|
| -13
| 47.5%
| -9.7%
| -5.9%
| -€20.15K
|
| PerkinElmer, Inc.
|
| 46
| 59.1%
| 12.0%
| 2.0%
| €12.75K
|
| Predilife S.A.
|
| -3.2
| -1,061.4%
| -1,201.4%
| -174.5%
| -€224.46K
|
| ANGLE plc
|
| -1.1
| 62.3%
| -627.7%
| -87.3%
| -€151.98K
|
| Biocept, Inc.
|
| -0.013
| 555.8%
| 1,088.2%
| -157.9%
| -€605.67K
|
| Quest Diagnostics Incorporated
|
| 20
| 33.3%
| 14.0%
| 6.0%
| €15.27K
|
| Response Genetics, Inc
|
| -0.00026
| 40.5%
| -79.3%
| -137.7%
| -€134.16K
|
| Ever Fortune.AI Co., Ltd.
|
| 96
| 62.4%
| 10.5%
| 3.5%
| €0.00
|
| T2 Biosystems, Inc.
|
| -0.092
| -77.7%
| -542.6%
| -237.6%
| -€329.83K
|
| BioPorto A/S
|
| -7.6
| 62.3%
| -256.6%
| -95.8%
| -€235.23K
|
| Synlab AG
|
| 27
| 49.8%
| 5.2%
| 1.9%
| €3.31K
|
| OPKO Health, Inc.
|
| -7.5
| 38.6%
| -17.5%
| -7.1%
| -€40.76K
|
| Bionano Genomics, Inc.
|
| -0.32
| 48.1%
| -127.9%
| -48.8%
| -€341.64K
|
| Imagion Biosystems Limited
|
| -1.1
| 35.6%
| -155.7%
| -236.1%
| €0.00
|
| Sonic Healthcare Limited
|
| 25
| 33.1%
| 30.3%
| 3.2%
| €7.29K
|
| Medivolve Inc.
|
| -0.058
| 58.9%
| -228.5%
| -597.4%
| -€352.79K
|
| BGI Genomics Co., Ltd.
|
| -26
| 39.7%
| -21.8%
| -6.5%
| -€27.18K
|
| Shin Nippon Biomedical Laboratories, Ltd.
|
| 11
| 49.8%
| 7.2%
| 5.7%
| €18.89K
|
| Aclaris Therapeutics, Inc.
|
| -1.2
| 31.0%
| -973.9%
| -80.7%
| -€2.02M
|
| Dr. Lal PathLabs Limited
|
| 48
| 58.9%
| 29.1%
| 0.0%
| €11.67K
|
| Integrative Health Technologies, Inc.
|
| -0.025
| 48.5%
| 56.2%
| -14.5%
| €0.00
|
| Psychemedics Corporation
|
| -8.4
| 36.1%
| -9.6%
| -22.4%
| -€13.92K
|
| Avricore Health Inc.
|
| -3.6
| 43.0%
| -20.7%
| -85.6%
| €0.00
|
| Vimta Labs Limited
|
| 30
| 59.1%
| 25.2%
| 0.0%
| €4.94K
|
| Biocartis Group NV
|
| -0.4
| 41.6%
| -71.6%
| -60.1%
| -€129.03K
|
| InVitro International
|
| 13
| 81.7%
| 9.5%
| 6.0%
| €17.45K
|
| BIONET Corp.
|
| 63
| 56.0%
| 1.4%
| 2.3%
| €0.00
|
| Applied DNA Sciences, Inc.
|
| -0.064
| 39.6%
| -406.1%
| -373.5%
| -€699.90K
|
| TFBS Bioscience Inc.
|
| -15
| 10.8%
| -43.9%
| -3.9%
| €0.00
|
| Australian Clinical Labs Limited
|
| 17
| 36.5%
| 36.5%
| 5.6%
| €3.95K
|
| Danaher Corporation
|
| 41
| 59.5%
| 19.0%
| 4.4%
| €49.83K
|
| Hangzhou Tigermed Consulting Co., Ltd.
|
| 928
| 29.1%
| 6.5%
| 1.0%
| €3.65K
|
| Immunovia AB (publ)
|
| -1
| -3,218.6%
| -10,914.6%
| -421.4%
| -€1.49M
|
| DermTech, Inc.
|
| -0.00000039
| 8.5%
| -580.3%
| -87.0%
| -€377.52K
|
| Guangzhou Wondfo Biotech Co.,Ltd
|
| 39
| 62.2%
| 10.2%
| 3.9%
| €10.21K
|
| Autobio Diagnostics Co., Ltd.
|
| 20
| 64.6%
| 25.9%
| 9.4%
| €23.92K
|
| Monash IVF Group Limited
|
| 10
| 33.2%
| 16.0%
| 5.1%
| €14.96K
|
| BioNexus Gene Lab Corp.
|
| -2.4
| 14.8%
| -24.8%
| -30.1%
| -€66.43K
|
| Thalys Medical Technology Group Inc.
|
| -10
| 18.7%
| -13.0%
| -11.5%
| -€21.51K
|
| Centro de Imagem Diagnósticos S.A.
|
| -9.1
| 26.8%
| 7.7%
| -2.7%
| -€2.70K
|
| IQVIA Holdings Inc.
|
| 21
| 33.8%
| 13.4%
| 4.5%
| €12.51K
|
| Diaceutics PLC
|
| -0.7
| 86.1%
| -6.4%
| -3.4%
| -€9.47K
|
| Neuronetics, Inc.
|
| -5.7
| 50.4%
| -29.2%
| -30.2%
| -€53.32K
|
| Precision System Science Co., Ltd.
|
| -23
| 29.4%
| -2.6%
| -5.1%
| -€8.71K
|
| Integral Diagnostics Limited
|
| 187
| 26.0%
| 14.7%
| 0.3%
| €1.41K
|
| GRAIL, Inc.
|
| -6.3
| -5.4%
| -471.3%
| -16.4%
| -€384.34K
|
| BioMaxima S.A.
|
| 87
| 35.3%
| 2.2%
| 0.9%
| €1.42K
|
| Eurofins-Cerep SA
|
| 17
| 26.5%
| 10.5%
| 7.3%
| €29.48K
|
| Access Bio, Inc.
|
| -11
| 20.8%
| -42.1%
| -3.3%
| €0.00
|
| Castle Biosciences, Inc.
|
| -43
| 65.3%
| -10.2%
| -2.2%
| -€13.54K
|
| Pacific Edge Limited
|
| -2.7
| 43.8%
| -172.6%
| -80.8%
| -€130.06K
|
| Metropolis Healthcare Limited
|
| 60
| 78.9%
| 25.3%
| 0.0%
| €3.29K
|
| RadNet, Inc.
|
| -339
| 9.6%
| 3.0%
| -0.3%
| -€1.00K
|
| VolitionRx Limited
|
| -2.5
| 100.0%
| -1,542.2%
| -354.8%
| -€233.55K
|
| IDenta Corp.
|
| -31
| 37.3%
| 2.2%
| -2.6%
| -€3.46K
|
| Arrayit Corporation
|
| -0.01
| 49.4%
| -238.7%
| -749.5%
| -€937.87K
|
| Suraksha Diagnostic Limited
|
| 49
| 80.8%
| 18.4%
| 0.0%
| €2.64K
|
| INOVIQ Ltd
|
| -6.8
| -85.9%
| -583.8%
| -37.6%
| -€275.57K
|
| Eurofins Scientific SE
|
| 34
| 14.2%
| 13.7%
| 2.9%
| €4.93K
|
| Acer Medical Inc.
|
| -64
| 58.8%
| -60.1%
| -14.5%
| -€37.40K
|
| Lonza Group AG
|
| 57
| 32.9%
| 15.3%
| 3.9%
| €44.21K
|
| BCAL Diagnostics Limited
|
| -3.5
| 100.0%
| -227.7%
| -73.1%
| €0.00
|
| CareDx, Inc
|
| 18
| 67.3%
| 14.7%
| 14.1%
| €81.87K
|
| bioAffinity Technologies, Inc.
|
| -0.56
| 26.2%
| -153.2%
| -127.6%
| -€224.36K
|
| Diagnósticos da América S.A.
|
| -1.9
| 28.6%
| 6.1%
| -4.9%
| -€9.49K
|
| Human Metabolome Technologies, Inc.
|
| 13
| 65.9%
| 21.5%
| 11.9%
| €29.89K
|
| Sofiva Genomics Co.,Ltd.
|
| -99
| 26.2%
| -8.6%
| -1.0%
| €0.00
|
| H.U. Group Holdings, Inc.
|
| 131
| 28.0%
| 1.2%
| 0.5%
| €1.40K
|
| Welgene Biotech Co.,Ltd.
|
| 206
| 42.4%
| 0.2%
| 0.4%
| €779.90
|
| Dian Diagnostics Group Co.,Ltd.
|
| -20
| 28.7%
| -1.2%
| -2.9%
| -€6.19K
|
| Clínica Baviera, S.A.
|
| 18
| 80.4%
| 28.4%
| 17.6%
| €22.92K
|
| Invitae Corporation
|
| -0.0037
| 27.1%
| -303.5%
| -269.2%
| -€735.29K
|
| Genetics Generation Advancement Corp.
|
| 46
| 41.7%
| 4.2%
| 4.9%
| €0.00
|
| Twist Bioscience Corporation
|
| -27
| 50.7%
| -36.2%
| -12.1%
| -€72.86K
|
| Guardant Health, Inc.
|
| -15
| 63.8%
| -49.0%
| -31.2%
| -€173.10K
|
| Shanghai Runda Medical Technology Co., Ltd.
|
| -68
| 22.4%
| 1.1%
| -1.1%
| -€5.99K
|
| Amoy Diagnostics Co., Ltd.
|
| 29
| 84.0%
| 28.8%
| 12.9%
| €31.90K
|
| Neogen Corporation
|
| -1.2
| 43.8%
| -121.7%
| -30.9%
| -€310.28K
|
| Voxel S.A.
|
| 17
| 28.6%
| 22.9%
| 16.2%
| €72.83K
|
| MDxHealth SA
|
| -6.5
| 61.4%
| -25.6%
| -11.7%
| -€63.25K
|
| Bangkok Genomics Innovation Public Company Limited
|
| 1.2K
| 41.3%
| 12.9%
| 6.6%
| €0.00
|
| DiaSorin S.p.A.
|
| 27
| 65.7%
| 23.1%
| 6.6%
| €58.60K
|
| BioMark Diagnostics Inc.
|
| -17
| 62.2%
| -751.3%
| -64.7%
| €0.00
|
| AmCad BioMed Corporation
|
| -18
| 54.5%
| -170.4%
| -8.8%
| €0.00
|
| Thermo Fisher Scientific Inc.
|
| 24
| 42.0%
| 17.2%
| 6.4%
| €45.61K
|
| SeqLL Inc.
|
| -1.3
| 10.9%
| -7.3%
| -91.5%
| -€291.93K
|
| Pangaea Oncology, S.A.
|
| -49
| 100.1%
| 14.4%
| -3.6%
| -€7.34K
|
| GENinCode plc
|
| -0.015
| 46.3%
| -192.2%
| -166.5%
| -€120.99K
|
| Cosmo Bio Company,Limited
|
| 29
| 33.4%
| 2.8%
| 2.1%
| €7.65K
|
| Prostatype Genomics AB (publ)
|
| -0.93
| -1,570.3%
| -5,798.6%
| -103.3%
| -€689.72K
|
| Maccura Biotechnology Co.Ltd
|
| -61
| 53.9%
| -3.9%
| -1.5%
| -€4.40K
|
| Personalis, Inc.
|
| -6.9
| 26.7%
| -117.1%
| -30.4%
| -€281.17K
|
| American Bio Medica Corporation
|
| 0.0013
| -19.9%
| -439.3%
| 0.0%
| €197.18K
|
| Krsnaa Diagnostics Limited
|
| 27
| 62.5%
| 23.5%
| 0.0%
| €2.02K
|
| RushNet, Inc.
|
| -0.0095
| 68.7%
| -25.0%
| -19.9%
| -€43.54K
|
| StageZero Life Sciences Ltd.
|
| -1.8
| 16.9%
| -95.1%
| -247.1%
| -€31.13K
|
| Charles River Laboratories International, Inc.
|
| -88
| 32.1%
| 3.5%
| -1.1%
| -€3.87K
|
| Guangdong Hybribio Biotech Co.,Ltd.
|
| -6.9
| 42.3%
| -74.9%
| -12.2%
| -€24.54K
|
| Agilent Technologies, Inc.
|
| 26
| 52.4%
| 21.3%
| 10.2%
| €63.16K
|
| BML, Inc.
|
| 19
| 31.9%
| 6.6%
| 3.7%
| €7.73K
|
| HTG Molecular Diagnostics, Inc.
|
| -0.000011
| 21.7%
| -315.2%
| -185.5%
| -€329.91K
|
| Chembio Diagnostics, Inc.
|
| -0.71
| 20.2%
| -48.9%
| -37.2%
| -€107.49K
|
| Genedrive Plc
|
| -0.013
| 71.9%
| -901.0%
| -183.8%
| -€196.30K
|
| Biosynex SA
|
| -0.53
| -19.8%
| -20.8%
| -22.2%
| -€84.08K
|
| Genetic Signatures Limited
|
| -4.5
| -15.0%
| -100.0%
| -36.8%
| €0.00
|
